Related Experiment Video
Updated: Jun 9, 2025
07:45
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
1.8K
Spatial immunogenomic patterns associated with lymph node metastasis in lung adenocarcinoma
Fanjie Meng1, Hao Li2, Ruoyi Jin2,3,4
1Department of Thoracic Surgery, Beijing Institute of Respiratory Medicine and Beijing Chao Yang Hospital, Capital Medical University, Beijing, China.
Experimental Hematology & Oncology
|October 29, 2024
Summary
Researchers identified key genetic and immune patterns in lung adenocarcinoma (LUAD) linked to lymph node (LN) metastasis. A new predictive model aids personalized treatment for LUAD patients with LN spread.
Area of Science:
- Oncology
- Immunogenomics
- Genetics
Background:
- Lymph node (LN) metastasis in lung adenocarcinoma (LUAD) correlates with poor prognosis.
- Mechanisms driving LN metastasis in LUAD are not fully understood.
- This study investigates the immunogenomic landscape of LUAD with LN metastasis.
Purpose of the Study:
- To elucidate the immunogenomic landscape associated with lymph node metastasis in lung adenocarcinoma.
- To identify genetic alterations and immune microenvironment features linked to LN metastasis.
- To develop a predictive model for LN metastasis in LUAD patients.
Main Methods:
- Broad-panel next-generation sequencing (NGS) on 257 LUAD patients.
- Multiplex immunohistochemistry (mIHC) to profile the immune microenvironment.
- Integration of NGS and mIHC data to identify spatial immunogenomic patterns.
- Development and independent validation of a predictive model for LN metastasis.
Main Results:
- Distinct immunogenomic alterations correlate with LN metastasis.
- Increased mutation frequencies in PIK3CG and ATM observed in LN metastatic tumors.
- LN-positive tumors show higher prevalence of macrophages and regulatory T cells.
- A novel predictive model for LN metastasis likelihood was developed.
Conclusions:
- Identified key immunogenomic patterns driving LUAD metastatic progression.
- The predictive model advances personalized treatment strategies for LUAD.
- Findings offer potential for improved patient management, especially for those ineligible for surgery.
